Stockscreener 앱 받기
0.5344
0.23%
0.0012
시간 외 거래:
.51
-0.0244
-4.57%
Mangoceuticals Inc 주식(MGRX)의 최신 뉴스
MANGOCEUTICALS, INC. Q2 2026: Revenue $68.76K, EPS $(0.09) — 10-Q Summary - TradingView
Mangoceuticals (MGRX) Q2 2026 loss shrinks while cash and revenue fall - Stock Titan
Mangoceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
12 Consumer Staples Stocks Moving In Thursday's After-Market Session - Benzinga
Nuclea’s planned Moltex deal could add 80 nuclear patents - Stock Titan
Why is Mangoceuticals stock surging today? - Investing.com India
On Thursday, there are stocks with unusual volume. Let's take a look. - ChartMill
Why is Mangoceuticals stock surging today? By Investing.com - Investing.com South Africa
Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - The Manila Times
Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs - globenewswire.com
Mangoceuticals (MGRX) merger partner Nuclea inks Utah nuclear test reactor MOU - Stock Titan
Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why - Benzinga
Mangoceuticals merger partner Nuclea signs MOU with New Mining on modular reactor power for data centers - Bitget
Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - The Globe and Mail
Wondering what's happening in today's after-hours session? - ChartMill
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - Yahoo Finance
Mangoceuticals (NASDAQ: MGRX) wins more time on Nasdaq rules, advances Nuclea deal - Stock Titan
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - The Manila Times
Mangoceuticals Inc. (MGRX) Slides 15% to $0.45 as Selling Pressure IntensifiesSmart Money Flow Stocks - dars.gov.et
$Mangoceuticals (MGRX.US)$ - Moomoo
Mangoceuticals, Inc. Common Stock (NASDAQ: MGRX) Stock Price, News & Analysis - Kalkine
Microcaps MGRX, PRSO, IGC, KUST In the News to Watch - openPR.com
That’s quite fortunate! - Moomoo
$Mangoceuticals (MGRX.US)$ wow finally CB ⬆️ [Grin][Drool][Cool Guy][Angry][Tongue] - moomoo.com
$Mangoceuticals (MGRX.US)$ sold a tad early. but definitely looking for another entry! - Moomoo
Mangoceuticals (NASDAQ:MGRX) Shares Surge Almost Threefold Following Nuclea Agreement; Existing Shareholders Retain 4% - TechStock²
Form 4 Mangoceuticals Inc For: 30 July By Investing.com - Investing.com Canada
Nuclea Energy to go public via merger with Mangoceuticals By Investing.com - Investing.com Nigeria
Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - newsfilecorp.com
Nuclea Energy Inc: Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor - FinanzNachrichten.de
Mangoceuticals agrees to merge with nuclear microreactor developer - Investing.com Nigeria
Mangoceuticals agrees to merge with nuclear microreactor developer By Investing.com - Investing.com Canada
Jacob D. Cohen to Leave CEO Role at Mangoceuticals, Becomes President in Consulting Role - TradingView
Mangoceuticals to merge with Nuclea Energy to a... - Pluang
Mangoceuticals Inc (MGRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mangoceuticals Inc (MGRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mangoceuticals Inc (MGRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mangoceuticals Inc (MGRX) Cash Flow - TradingKey
Mangoceuticals Inc (MGRX) Income Statement - TradingKey
MGRX|Mangoceuticals Inc|Price:0.542|Chg%:-0.001 - TradingKey
MGRX|Mangoceuticals Inc|Price:0.521|Chg%:-0.037 - TradingKey
Mangoceuticals (MGRX) Slips 6.58% as Stock Tests Critical Support LevelsDaily Profile - dars.gov.et
Mangoceuticals Inc (MGRX) Institutional Confidence - TradingKey
Mangoceuticals, Inc. Revenue Breakdown – NASDAQ:MGRX - TradingView
Mangoceuticals Inc (MGRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mangoceuticals stock doubles after Texas lawsuit - MSN
MGRX Q3 2025 Earnings: Net Loss Widens as Pre-Revenue Biotech Focuses on Clinical PipelineNet Profit Margin - po-news-eg.net
Price to sales forward of Mangoceuticals, Inc. – BOATS:MGRX - TradingView
Mangoceuticals (MGRX) Slips 2.46% as Stock Approaches Key Support at $0.34Zero Gamma Level - dars.gov.et
MGRX Q3 2025 Earnings: Wider Loss Reported as Stock Gains Despite Opaque Financial DisclosureBasic EPS Analysis - dars.gov.et
Price to earnings forward of Mangoceuticals, Inc. – NASDAQ:MGRX - TradingView
ETFs Investing in Mangoceuticals, Inc. Stocks - TradingView
Mangoceuticals (MGRX) Surges 10% as Stock Bounces from Key Support LevelGEX Level - dars.gov.et
Mangoceuticals, Inc. Subscription Agreement: Accredited Investor Requirements & SEC Compliance Explained - Minichart
Mangoceuticals Raises Capital via Private Equity Placement - TipRanks
Mangoceuticals (MGRX) completes $272,000 private placement of common shares - Stock Titan
Mangoceuticals Inc. (MGRX) Faces Continued Pressure, Testing Key Support Near $0.34Strangle Setup - dars.gov.et
Mangoceuticals, Inc. announced that it has received $0.272 million in funding - marketscreener.com
Mangoceuticals Inc (MGRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mangoceuticals (MGRX) Rallies 3.46% as Buyers Defend $0.34 SupportFade Trade - dars.gov.et
1.10%
6.73%
자본화:
|
볼륨(24시간):